Segregation of mitochondrial DNA mutations in the human placenta: implication for prenatal diagnosis of mtDNA disorders
- 28 July 2017
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 55 (2) , 131-136
Abstract
Background Mitochondrial DNA (mtDNA) disorders have a high clinical variability, mainly explained by variation of the mutant load across tissues. The high recurrence risk of these serious diseases commonly results in requests from at-risk couples for prenatal diagnosis (PND), based on determination of the mutant load on a chorionic villous sample (CVS). Such procedures are hampered by the lack of data regarding mtDNA segregation in the placenta. The objectives of this report were to determine whether mutant loads (1) are homogeneously distributed across the whole placentas, (2) correlate with those in amniocytes and cord blood cells and (3) correlate with the mtDNA copy number. Methods We collected 11 whole placentas carrying various mtDNA mutations (m.3243A>G, m.8344A>G, m.8993T>G, m.9185T>C and m.10197G>A) and, when possible, corresponding amniotic fluid samples (AFSs) and cord blood samples. We measured mutant loads in multiple samples from each placenta (n= 6–37), amniocytes and cord blood cells, as well as total mtDNA content in placenta samples. Results Load distribution was homogeneous at the sample level when average mutant load was low (80%) at the whole placenta level. By contrast, a marked heterogeneity was observed (up to 43%) in the intermediate range (20%–80%), the closer it was to 40%–50% the mutant load, the wider the distribution. Mutant loads were found to be similar in amniocytes and cord blood cells, at variance with placenta samples. mtDNA content correlated to mutant load in m.3243A>G placentas only. Conclusion These data indicate that (1) mutant load determined from CVS has to be interpreted with caution for PND of some mtDNA disorders and should be associated with/substituted by a mutant load measurement on amniocytes; (2) the m.3243A>G mutation behaves differently from other mtDNA mutations with respect to the impact on mtDNA copy number, as previously shown in human preimplantation embryogenesis.Keywords
Funding Information
- Agence de Biomedecine
- AFM-Téléthon
This publication has 14 references indexed in Scilit:
- A national perspective on prenatal testing for mitochondrial diseaseEuropean Journal of Human Genetics, 2014
- Segregation of mtDNA throughout human embryofetal development: m.3243A>G as a model systemHuman Mutation, 2010
- Previous Estimates of Mitochondrial DNA Mutation Level Variance Did Not Account for Sampling Error: Comparing the mtDNA Genetic Bottleneck in Mice and HumansThe American Journal of Human Genetics, 2010
- Preventing transmission of maternally inherited mitochondrial DNA diseasesBMJ, 2009
- Stability of the m.8993T→G mtDNA mutation load during human embryofetal development has implications for the feasibility of prenatal diagnosis in NARP syndromeJournal of Medical Genetics, 2007
- Prenatal diagnosis of myopathy, encephalopathy, lactic acidosis, and stroke-like syndrome: contribution to understanding mitochondrial DNA segregation during human embryofetal developmentJournal of Medical Genetics, 2006
- Mosaicism for mitochondrial DNA polymorphic variants in placenta has implications for the feasibility of prenatal diagnosis in mtDNA diseasesEuropean Journal of Human Genetics, 2006
- Transmission and prenatal diagnosis of the T9176C mitochondrial DNA mutationMolecular Human Reproduction, 2004
- Genetic Counseling and Prenatal Diagnosis for the Mitochondrial DNA Mutations at Nucleotide 8993The American Journal of Human Genetics, 1999
- Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypesBrain, 1997